Anirban Maitra Profile picture
Pancreatic cancer researcher and GI pathologist. Striving to improve the lives of patients with cancer.
Dec 30, 2022 13 tweets 12 min read
2022 was the year mutant KRAS in #PancreaticCancer truly became actionable.

Direct KRAS targeting & #PancreaticCancer, a 🧵: In @NEJM by @DavidHongMD & colleagues:
Sotorasib in KRAS p.G12C–Mutated Advanced #PancreaticCancer
nejm.org/doi/full/10.10…
G12C is ~1.6% of KRAS alleles in pancreatic cancer, & monotherapy responses in pre-treated patients are mostly transient stable disease, but a step forward.